Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aditxt Inc
(NQ:
ADTX
)
1.500
+0.030 (+2.04%)
Streaming Delayed Price
Updated: 12:25 PM EDT, Jul 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Aditxt Inc
< Previous
1
2
3
4
5
6
Next >
Transplant Team at UW Medicine Completes Groundbreaking Surgery
October 03, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Regains Compliance with Nasdaq Listing Requirements
September 29, 2022
Via
Investor Brand Network
Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements
September 29, 2022
From
Aditxt, Inc.
Via
Business Wire
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Issues Corporate Update Following Reverse Stock Split, Closing of $20M Public Offering
September 27, 2022
Via
Investor Brand Network
Researchers Believe Seasonal Allergies Are Worsening
July 08, 2022
Via
Investor Brand Network
Aditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights Post Reverse Stock Split and Closing of $20M Public Offering
September 27, 2022
From
Aditxt, Inc.
Via
Business Wire
UBC Scientists Believe Insulin Tablet to Treat Diabetes May Soon Be Available
September 26, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on Recently Announced $20M Public Offering
September 21, 2022
Via
Investor Brand Network
Aditxt Announces Closing of $20.0 Million Public Offering
September 20, 2022
From
Aditxt, Inc.
Via
Business Wire
The US Reaches One Million Organ Transplants
September 16, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Pricing of Public Offering
September 16, 2022
Via
Investor Brand Network
Aditxt Announces Pricing of $20.0 Million Public Offering
September 16, 2022
From
Aditxt
Via
Business Wire
Aditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022
September 13, 2022
From
Aditxt, Inc.
Via
Business Wire
Researchers Find Link Between Steroidal Allergy Treatments, Decreased Brain Function
September 08, 2022
Via
Investor Brand Network
Study Finds Children Have Better Outcomes with Kidney Transplants from Living Donors
August 30, 2022
Via
Investor Brand Network
Study Finds That Early Exposure to Antibiotics May Trigger Asthma, Permanent Allergies
August 23, 2022
Via
Investor Brand Network
Senate Review Reveals Screening Mistakes Caused Organ Transplant Failures, Illnesses, Deaths
August 15, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Looking to Solve Medical Challenge in Immune Responses
August 12, 2022
Via
Investor Brand Network
Combining Immunotherapy with Anti-Rejection Drugs Can Treat Cancer, Prevent Kidney Transplant Rejection
August 05, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Featured in Bell2Bell Podcast
August 02, 2022
Via
Investor Brand Network
Exposures
COVID-19
Aditxt Inc. (NASDAQ: ADTX) Seeks to Address Variability of Immune Responses
August 02, 2022
Via
Investor Brand Network
Study Finds That Introducing Some Foods to Infants Early Reduces Risks of Allergies
July 28, 2022
Via
Investor Brand Network
Study Highlights New Insights on Neurological Autoimmune Illnesses
July 19, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Equipping Physicians, Individuals with Comprehensive Immune System Views
July 14, 2022
Via
Investor Brand Network
Exposures
COVID-19
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Moves One Step Closer to In-Human Trials with Completion of Preclinical Toxicity Study
July 08, 2022
Via
Investor Brand Network
Aditxt, Inc. Successfully Completes Preclinical Toxicity Study of Its Psoriasis Drug Candidate ADI™-100 Advancing it Closer to First-in-Human Trials
July 08, 2022
From
Aditxt, Inc.
Via
Business Wire
Virtual Biopsies May Revolutionize Procedures Used in Heart Transplants
June 30, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Pursuing Strategy Against COVID-19, Immune System-Related Maladies
June 28, 2022
Via
Investor Brand Network
Exposures
COVID-19
Hope of Herd Immunity Dwindles Alongside Federal COVID-19 Budget and Supplies; Aditxt Inc. (NASDAQ: ADTX) and AditxtScore(TM) Could Create Map to COVID-19 Immune Responses
June 24, 2022
Via
Investor Brand Network
Exposures
COVID-19
Uncertainty Causes Patients with Systemic Autoimmune Conditions to Be Depressed
June 23, 2022
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.